Concourse Financial Group Securities’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,240
Closed -$52.1K 5269
2024
Q4
$52.1K Sell
4,240
-321
-7% -$3.94K ﹤0.01% 1194
2024
Q3
$125K Buy
4,561
+117
+3% +$3.21K 0.01% 880
2024
Q2
$109K Buy
4,444
+30
+0.7% +$734 0.01% 909
2024
Q1
$94.1K Sell
4,414
-64
-1% -$1.36K 0.01% 938
2023
Q4
$85.7K Sell
4,478
-806
-15% -$15.4K 0.01% 944
2023
Q3
$84.8K Sell
5,284
-110
-2% -$1.76K 0.01% 905
2023
Q2
$125K Buy
5,394
+370
+7% +$8.58K 0.01% 795
2023
Q1
$117K Sell
5,024
-410
-8% -$9.52K 0.01% 822
2022
Q4
$78.8K Sell
5,434
-103
-2% -$1.5K 0.01% 911
2022
Q3
$106K Sell
5,537
-204
-4% -$3.91K 0.01% 706
2022
Q2
$104K Buy
5,741
+572
+11% +$10.4K 0.01% 796
2022
Q1
$130K Sell
5,169
-43
-0.8% -$1.08K 0.01% 769
2021
Q4
$144K Buy
5,212
+195
+4% +$5.39K 0.01% 845
2021
Q3
$162K Sell
5,017
-235
-4% -$7.59K 0.01% 793
2021
Q2
$161K Sell
5,252
-1,346
-20% -$41.3K 0.01% 783
2021
Q1
$201K Sell
6,598
-524
-7% -$16K 0.01% 686
2020
Q4
$141K Buy
7,122
+2,346
+49% +$46.4K 0.01% 753
2020
Q3
$62K Buy
4,776
+287
+6% +$3.73K 0.01% 973
2020
Q2
$51K Buy
4,489
+1,510
+51% +$17.2K 0.01% 982
2020
Q1
$43K Buy
+2,979
New +$43K ﹤0.01% 963
2019
Q4
Hold
0
4377
2019
Q3
Hold
0
4167
2019
Q2
Hold
0
4364
2019
Q1
Hold
0
4304
2018
Q4
Hold
0
4182
2018
Q3
Hold
0
3895